Capital Planning Advisors, LLC Edwards Lifesciences Corp Transaction History

Capital Planning Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $893,055 - $1.16 Million	-10,842 Reduced 60.4%	7,109 $587,000
Q2 2022 Aug 10, 2022	BUY	$86.5 - $128.27 $28,718 - $42,585	332 Added 1.88%	17,951 $1.71 Million
Q1 2022 May 10, 2022	BUY	$101.96 - $128.34 $24,878 - $31,314	244 Added 1.4%	17,619 $2.07 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $12,870 - $15,812	-121 Reduced 0.69%	17,375 $2.25 Million
Q3 2021 Nov 09, 2021	SELL	$102.91 - $122.75 $16,568 - $19,762	-161 Reduced 0.91%	17,496 $1.98 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $4,527 - $5,657	-54 Reduced 0.3%	17,657 $1.83 Million
Q1 2021 Apr 30, 2021	BUY	$78.68 - $90.67 $617,874 - $712,031	7,853 Added 79.66%	17,711 $1.48 Million
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $10,108 - $12,863	141 Added 1.45%	9,858 $899,000
Q3 2020 Nov 12, 2020	BUY	$67.19 - $87.44 $89,833 - $116,907	1,337 Added 15.95%	9,717 $776,000
Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $482,185 - $644,841	8,380 New	8,380 $579,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Planning Advisors, LLC with notifications on news.